Familial homozygous hypercholesterolemia: Effective long-term treatment with cascade double filtration plasmapheresis

Blood Purification

Volumn 19, Issue 3, 2001, Pages 308-313

  Demetriou, Kyproula ^a   H'Maltezou, Eleni ^a   Pierides, Alkis M ^a  

^a NICOSIA GENERAL HOSPITAL   (Cyprus)

Author keywords

Atherosclerosis; Double filtration; Homozygous; Hypercholesterolemia; Xanthomata

Indexed keywords

CHOLESTEROL;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FAMILIAL HYPERCHOLESTEROLEMIA; FILTRATION; HOMOZYGOSITY; HUMAN; LONG TERM CARE; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; PLASMAPHERESIS; TIME FACTORS;

EID: 0035099919     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046959     Document Type: Article

References (36)

1. Familial hypercholesterolaemia
2. Coronary disease in familial hypercholesterolemia
3. Decreased production of low-density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia
4. An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor
5. Ileal bypass in the treatment of hyperlipoproteinaemia
6. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the program on the surgical control of the hyperlipidemias (POSCH)
7. Portocaval shunt and liver transplantation in the treatment of familial hypercholesterolemia
8. Treatment of familial hypercholesterolemia by portocaval anastomosis: Effect on cholesterol metabolism and pool sites
9. Plasma exchange in the management of homozygous familial hypercholesterolaemia
10. Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange
11. Plasma exchange therapy of homozygous familial hypercholesterolemia
12. Regression of valvular aortic stenosis due to homozygous familial hypercholesterolemia following plasmapheresis
13. Familial hypercholesterolaemia regression study: A randomised trial of low-density-lipoprotein apheresis
14. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
15. LDL-Apheresis Atherosclerosis Regression Study (LAARS): Effect of aggressive versus conventional lipid-lowering treatment on coronary atherosclerosis
16. Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia
17. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia
18. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolemia
19. The HELP-LDL Apheresis Multicentre Study: An angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effects of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease
20. Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis
21. Cascade filtration for LDL apheresis: Increase of selectivity
22. Plasmapheresis in a six-year-old boy with homozygous familial hypercholesterolemia
23. Lipid apheresis by hemoperfusion: In vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood
24. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia
25. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia
26. Homozygous familial hypercholesterolemia among French Canadians in Quebec province
27. A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews
28. The Lebanese allele at the low density lipoprotein receptor locus
29. Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: A comparison of two geographical areas
30. A double mutant LDL receptor allele in a Cypriot family with heterozygous familial hypercholesterolemia
31. Geographical clustering of low density lipoprotein receptor gene mutations (C292X, Q363X, D365E & C660X) in Cyprus
32. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia
33. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia
34. Mutational and genetic origin of LDL receptor gene mutations in both Belgian and Dutch familial hypercholesterolemics
35. Experiences with homozygous cases of familial hypercholesterolemia: A report of 52 patients
36. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses